Currently included on this page are:
SaBTO Microbiological Safety Guidelines
2018 National AMR Campaign
Healthcare professional survey - pharma communications strategies
Immediate ART for treatment of HIV-1 in adults and adolescents
BIA CSC Position Statement on the determination of Consultant Competence
HEE report: evaluation of our antimicrobial resistance introductory e-learning session
ARK (Antibiotic Review Kit) - a research programme aiming to safely reduce antibiotic use in hospitals
TARGET webinar series: How to optimise antibiotic prescribing in primary care
AMPS Competencies Report
A new revision of the guide to the microbiological safety of human organs, tissues and cells used in transplantation, now renamed as the SaBTO microbiological safety guidelines, has been published. The new guidelines are available on the SaBTO website.
The 2018 National AMR campaign was launched in March, and will run until September 2018.
This is a highly targeted national AMR awareness and educational campaign titled “Drug Resistance” in partnership with ESCMID, BIVDA and BSAC reaching key stakeholders such as Clinical Microbiologists, Government, CCG’s and the public. Details of the campaign, and its aim are below.
Campaign title: 2018 Drug Resistance (AMR)
Launch date: 9th of March running until September 2018
Format: Multi- platform campaign: 16-page print publication in the Guardian, online via www.globalcause.co.uk, events, conferences and via social media
Aim: To provide an educational, action and implementation campaign around antimicrobial resistance and the need to preserve the effectiveness of antibiotics
Target Audience: HCP’s (Clinical and non- clinical), Investors, policy makers, Industry and the public
Further information is available at www.globalcause.co.uk
Do you want to influence how you communicate with Pharma?
This survey is around pharma’s relationship with doctors and what they feel is appropriate / optimal in terms of content / channel of communication. The idea is to raise awareness in the pharmaceutical industry of how doctors want to be communicated with. The results of the survey will be published in the pharmaceutical press (pharmaphorum) as well as circulated through industry contacts. This is an opportunity for doctors to have a say in the way that they communicate with the pharma industry and should hopefully help to stimulate meaningful debate at a time where the relationship is somewhat strained.
We note that RCPath have also produced a position statement which was published on 10/07/2017. Both documents are entirely congruent. We hope that the BIA document provides additional specific advice on provision of evidence that would be acceptable to UKAS. We are sharing our document with UKAS this week.
Posted 10/07/17; update posted 04/01/18
From: Professor Ged Byrne and Professor Lisa Bayliss-Pratt
We are pleased to let you know that our work to evaluate the visibility and uptake of the introductory e-learning session on antimicrobial resistance that also includes national infection prevention and control training is now available to access on our website.
As outlined in our Mandate, we were asked to assess individual and organisational buy-in and usage of this introductory e-learning session on antimicrobial resistance. The government’s call for action as set out in the UK Five Year Antimicrobial Resistance Strategy 2013 to 2018 requires Health Education England (HEE) to lead improvements in the education and training of healthcare workers and have a role in helping strengthen curricula on antimicrobial resistance, responsible prescribing, infection prevention and control and develop e-learning tools to support this.
To begin this work, last year we asked higher education institutions about the extent to which the antimicrobial prescribing and stewardship competences developed by Public Health England and the Government’s advisory committee on antimicrobial resistance and healthcare associated infection (ARHAI) have been embedded into their curricula. We also explored whether there are any gap areas in the educational resources that are available to support current prescribers with the prescribing of antimicrobials.
Our evaluation on the visibility and uptake of this introductory e-learning session on antimicrobial resistance showed that:
- Awareness of the introductory e-learning session on antimicrobial resistance is high.
- More than half of the respondents found this session beneficial in raising health-worker awareness on antimicrobial resistance and/or infection prevention and control and/or antimicrobial stewardship.
- More than half are not actively promoting this session to staff although there is enthusiasm for organisations to do more to promote this to staff.
- The majority of organisations are recommending this session as a non-mandatory training resource although more than half will consider making this mandatory for all staff.
Reducing infections in the NHS is a national priority, and the Government has outlined its desire to halve both healthcare associated Gram-negative bloodstream infections and inappropriate antibiotic prescribing in England by 2020. To help achieve these aims, we have set out a number of recommended actions targeted at ourselves, healthcare providers and other stakeholders within this report.
For further information please contact Mohamed Sadak (Clinical Lead and Programme Manager, Antimicrobial Resistance and Sepsis) firstname.lastname@example.org
ARK (Antibiotic Review Kit) - a research programme aiming to safely reduce antibiotic use in hospitals
Update June 2017:
ARK Feasibility Study
We started our feasibility assessment of ARK in Brighton in April and are just coming up to three months. We have had an amazing level of engagement from clinicians including medical staff, pharmacists and nurses. We have had over 150 people complete the online learning module so far. This is now embedded in our mandatory training and staff induction program. The decision aid is now embedded in our drug chart. Antibiotic stop rates at review have gone up from around 8% (using the ARK audit tool we have developed which is much more stringent than the tool we used for the CQUIN data) to over 30%. Clinician and patient feedback has been excellent.
Over the last few months we have secured endorsement of the ARK Hospital project from British Society for Antimicrobial Chemotherapy, the Society for Acute Medicine, the UK Clinical Pharmacy Network and the British Infection Association. The staff here in Brighton who have done the online module will be receiving their certificates over the next two weeks.
ARK pilot sites and full trial.
The pilot sites will open from September 2017 onwards. We are now starting monthly teleconferences with them as they get ready. Our aim if all goes well is to include data from some at least of these in the main trial and recruit the first sites to the main trial to start in Jan 2018. This means we want to start working with sites for the main trial in September 2017.
ARK on the web
We now have our website up and running. It is at www.arkstudy.ox.ac.uk
We have started putting updates on the news pages. Please be patient while we get better at uploading and formatting posts!
We have a twitter account which you can follow at @ARK_Hospital
In case you haven’t seen it, the wonderful FINGERTIPS resource http://fingertips.phe.org.uk/profile/amr-local-indicators now has Trust-level data for antibiotic prescription reviews. From these data, it looks like the median stop rate is 7.5%. Our experience suggests that Trusts are likely to be overestimating their true stop rate. We think our tool is better and just to repeat, our stop rates increased to over 30%. If you haven’t already, check out your own Trust’s data on Fingertips.
If you would like any further information please don’t hesitate to get in touch directly or through the website. I hope many of you will want to join the full ARK trial and be interested in getting set up for this in the autumn.
Martin Llewelyn PhD FRCP DTMH
Consultant, Department of Microbiology and Infection
Brighton and Sussex University Hospitals NHS Trust
Professor of Infectious Diseases
Brighton and Sussex Medical School
University of Sussex
Public Health England (PHE) and the British Society for Antimicrobial Chemotherapy (BSAC) have worked with primary care colleagues to develop a series of 7 free TARGET antibiotics webinars highlighting key easy actions you can take to help improve your antibiotic prescribing, and at the same time improve the patient experience and their self-care, therefore freeing up your time.
The webinar series is now complete, but videos are available to view - click for TARGET website
Posted 19/10/16 (updated 03/01/17)
The Health Education England survey of higher education institutions about embedding national antimicrobial prescribing and stewardship competences into curricula is now available to access on our website.
The antimicrobial prescribing and stewardship (AMPS) competences, produced jointly by the Government's expert advisory group for antimicrobial resistance and healthcare acquired infections (ARHAI), and Public Health England were published in 2013. Implementing these competences forms a key aspect of ‘Key area 3’ of the Government's five year strategy for tackling antimicrobial resistance - improving professional education, training and public engagement to improve clinical practice and promote wider understanding of the need for more sustainable use of antimicrobials. The antimicrobial prescribing and stewardship (AMPS) competences can provide clarity for regulators, education providers and professional bodies to inform standards, guidance and the development of training.
Undergraduate students have expressed interest in receiving more education about antimicrobials, especially about their multidisciplinary use. This survey asked higher education institutions about their awareness of the competencies, and how they had embedded them into their courses.
Virtual Doctors is a small charity which provides email advice to rural health workers in Africa and is currently looking to recruit more volunteer doctors (especially infectious diseases) based in the UK. Anyone interested in helping - particularly trainees, as this may be a good learning opportunity - should refer to the Virtual Doctors website for more information.